ALK-Positive Large B-Cell Lymphoma — Trials

ALK-Positive Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05544019	Study of SGR-1505 in Mature B-Cell Neoplasms	recruiting	Phase 1	98	Schrödinger, Inc.INDUSTRY	8	Feb 13, 2026	clinicaltrials
NCT06834373	Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy	recruiting	Phase 2	41	Mayo ClinicOTHER	1	Jan 28, 2026	clinicaltrials